Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Orphan Canada

Orphan Canada
2010 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of specialty pharmaceuticals licenses. The company provides licenses to commercialize therapies for rare disorders and specialty medicines in the Canadian market.

Formerly Known As
Gard Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Toronto, Ontario
  • Canada

Orphan Canada Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Orphan Canada‘s full profile, request access.

Request full access to PitchBook